We are pleased to host the 24th Annual Life Sciences BC Awards presented by Farris ceremony in person once again after two years of virtual celebrations. For the first time ever, we will be offering TWO distinct options for experiencing this signature event - similar to past years we will have the main Awards Gala room, and new this year, we're also offering an Awards Networking and Viewing Reception!
The well-known and highly esteemed Awards gala will be held in the main ballroom on the 3rd floor of the Vancouver Convention Centre West. Ticket holders for the main gala will enjoy a three-course plated meal and an optional glass of wine as they watch the awards ceremony live from their guest tables. Join in the celebration as award winners and other featured guests seated nearby are called to stage.
Gala guests will be able to network before and after the event, and during breaks, in the shared foyer with other gala ticket holders, as well as Networking and Viewing Reception guests.
Note: Tickets for this space are WAITLISTED. Please reach out to LSBC's Manager, Events Claire Nelson at email@example.com or add yourself to the waitlist through the tickets portal at the bottom of this page. Please note that ticket availability is not guaranteed. You will be notified by the LSBC team if a ticket becomes available.
Three-course plated meal
One glass of wine per person
Celebrate with Award winners in the main ballroom where awards are presented
A formal seating arrangement with banquet tables
LSBC Members - $299
Non-Members - $399
Networking and Viewing Reception Overview:
The Networking and Viewing Reception will be held in a space located next to the main gala room, set with a variety of cocktail tables and theatre-style seating, and will offer an array of stationed food options instead of a sit-down dinner. The ceremony will be streamed live onto large, flat-screen TVs in the reception room. Enjoy this more casual, networking-focused environment with other ticket holders, allowing you to enjoy the ceremonial, as well as social aspects, of the Awards event.
Networking and Viewing Reception guests will be able to network with Gala ticket holders before and after the event, and during breaks, in the shared foyer, and with other Networking Reception ticket holders throughout!
Note: Networking and Viewing Reception attendees will not have access to the main gala room where the ceremony will take place in-person. Ticket holders to the Networking Reception can also sign up to the gala waitlist and will be offered to switch ticket types should any become available.
Networking Reception Inclusions:
A variety of stationed canapes
1 drink ticket redeemable for wine or beer
Great networking opportunities
A more casual viewing environment
Networking Reception Cost:
LSBC members - $89
LSBC non-members - $149
Buy tickets to the Networking Reception or add yourself to the Gala waitlist here:
The 24th Annual Life Sciences BC Awards, presented by Farris on September 22nd, 2022, is an opportunity to celebrate our community's many achievements, small wins and big victories, with our peers, family and friends. This is our moment to recognize and honour the efforts of all those who have invested their lives' work in mastering successful health outcomes.
B.C. has found its place on the international life sciences stage and is recognized in Canada and beyond for its significant accomplishments in medical technology, biopharmaceuticals, health delivery systems, and medical research & development initiatives. We have reached beyond our borders to impact patient health and connect to the world at large, while ensuring the life science sector here, at home, remains vibrant and sustainable.
We are fortunate to have a life science ecosystem that bridges academia and a thriving research & development networks, including world-class healthcare facilities, distinguished health & medical foundations, and renowned centers of excellence that are supportive of translation and commercializing innovation in healthcare.
Please join us in celebrating our 2022 Life Sciences BC Award winners on September 22nd, 2022!
Founded in February 2009, Vancouver-based Acuitas Therapeutics is a private biotechnology company that specializes in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles. They partner with pharmaceutical and biotechnology companies and academic institutes to advance nucleic acid therapeutics into clinical trials and the marketplace.
The globally respected team works with partners to develop new therapies to address unmet clinical needs. This includes working with Pfizer/BioNTech for the COVID-19 vaccine COMIRNATY. They are focused on the advancement of treatments for diseases such as HIV/AIDS, cancer, tuberculosis, rabies, malaria and other serious diseases.
Precision NanoSystems is a global leader in technologies, solutions and services for the development of lipid nanoparticle delivered genomic medicines, including mRNA vaccines and therapeutics. They support (bio)pharma companies who are ushering in the next wave of genomic medicines in infectious diseases, cancer and rare diseases. They work with the world's leading drug developers to understand disease and help create the therapeutics and vaccines that will define the future of medicine. Our mission is to accelerate the creation of transformative medicine that significantly impacts human wellbeing.
Simon has spent more than 25 years dedicated to life sciences in British Columbia as a clinician, a scientist and an entrepreneur, both in the for-profit and the not-for-profit sectors.
Simon received his MD from the University of Cape Town in 1991 and his specialty internal medicine degree from UBC in 2001. He received his PhD in 1998 from the University of Amsterdam in lipid genetics and has published widely in the field. Simon continues to consult at the UBC Cardiology Clinic where he founded and is co-PI of SAVE BC, a provincial network dedicated to research, treatment and disease prevention in families with early coronary artery disease.
Simon has served on the Boards of numerous industry and healthcare associations including as chair of LifeSciences BC and Providence Healthcare Research Trust and vice-chair of BIOTECanada. He has played advisory roles to Michael Smith Foundation for Health Research and the Center for Molecular Medicine and Therapeutics and co-chaired the internationally recognized Science Technology and Innovation Council State of the Nation Report for the federal government.
Eupraxia is a Victoria B.C.-based clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to currently approved drugs. Each of Eupraxia's product candidates has the potential to address therapeutic areas with high unmet medical need and strives to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects.
Eupraxia's lead product candidate, EP-104IAR, is currently in Phase 2 development for the treatment of pain due to OA of the knee. In addition to EP-104IAR, Eupraxia is developing a pipeline of earlier-stage long-acting formulations. Potential pipeline candidates include a range of drugs for indications such as postsurgical pain (EP-105), and post-surgical site infections (EP-201), each designed to improve on the activity and tolerability of approved drugs.
Dr. Lauchlan Fraser, an ecosystem ecologist, is a Professor and Senior NSERC Industrial Research Chair in Ecosystem Reclamation at Thompson Rivers University. Fraser conducts research on ecosystem reclamation following industrial landscape disturbances, with a particular focus on biodiversity, climate change and grassland ecology, resulting in over 100 peer-reviewed publications in the world's leading scientific journals. His expertise is internationally recognized through invitations to serve on national and international boards and committees including the Genome BC Extractive Industries Sector Steering Committee, BC Technical and Research Committee on Reclamation, International Association of Vegetation Scientists Global Sponsorship Committee and board of the Grasslands Conservation Council of BC. He also holds editorial positions with several international scientific journals and serves as a referee for more than 50 journals.
Pieter R. Cullis, PhD, FRSC, FNAI (USA), OC, Director, Nanomedicines Research Group, Professor, Department of Biochemistry and Molecular Biology, University of British Columbia. Dr. Cullis and co-workers have been responsible for fundamental advances in the development of nanomedicines employing lipid nanoparticle (LNP) technology for cancer therapies, gene therapies and vaccines. This work has contributed to five drugs that have received clinical approval. Dr. Cullis has co-founded eleven biotechnology companies that now employ over 300 people, has published over 350 scientific articles and is an inventor on over 60 patents. He has also co-founded three not-for-profit enterprises including the Centre for Drug Research and Development (now AdMare) in 2004 and the NanoMedicines Innovation Network in 2019. Dr. Cullis has received numerous awards including the Order of Canada in 2021 and the VinFuture Prize, the Prince Mahidol Award and the Gairdner International Award in 2022. Two recently approved drugs that are enabled by LNP delivery systems devised by Dr. Cullis, members of his UBC laboratory and colleagues in the companies he has co-founded deserve special emphasis. The first is Onpattro which was approved by the US FDA in August 2018 to treat the previously fatal hereditary condition transthyretin-induced amyloidosis (hATTR). Onpattro is the first RNAi drug to receive regulatory approval. The second is Comirnaty, the COVID-19 vaccine developed by Pfizer/BioNTech that has received regulatory approval in many jurisdictions including Canada, the USA, the UK and Europe. Comirnaty is playing a major role in containing the global Covid-19 pandemic with approximately 3B doses administered worldwide in 2021.
Thrive Health was founded in 2016 by a diverse group of patients, clinicians, researchers, parents, and students who came together to help individuals going through complex care journeys. Their platform enables their customers to configure digital health and wellness solutions to deepen their relationships with and empower individuals in their care. Thrive Health operates across North America, headquartered in Vancouver BC, and they're on a mission to serve as a catalyst in the transformation of access to efficient, effective, empowered care for everyone.
With a wealth of globally-competitive scientific discovery, Canada is primed to lead the life sciences world. To make this a reality, at adMare BioInnovations, they use their scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems and industry-ready talent - and re-invest their returns back into the Canadian industry to ensure it is sustained for the long-term.
Genome BC is a not-for-profit organization supporting world-class genomics research and innovation to grow globally competitive life sciences sectors and deliver sustainable benefits for British Columbia, Canada and beyond. For more than 20 years, Genome BC has generated over $1.27 billion of investment in more than 498 genomics research and innovation projects, including over 1,000 collaborations with partners across BC and internationally. The organization's initiatives are improving the lives of people throughout BC by advancing health care in addition to addressing environmental and natural resource challenges. In addition to scientific programming, Genome BC works to integrate genomics into society by supporting responsible research and innovation and fostering an understanding and appreciation of the life sciences among educators, students and the public.
Life Sciences, Biotechnology, Biotech, Industry Association, Science
35,185Company Profile Views
LifeSciences British Columbia is an industry-funded association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry.
All life sciences sectors, from biopharmaceuticals and medical devices, to bioproducts and bioenergy, forest, agricultural and marine biotech, are integrated into our organization and all that we do, ensuring that no life sciences sector is working in isolation — and that all sectors come together in a comprehensive, complementary and coordinated fashion.
Throughout the year, LifeSciences BC undertakes numerous programs and projects in support of these sectors. These include public policy initiatives, facilitating linkages between global industry and our local organizations, raising the profile of our industry internationally and thus facilitating investment and global partnering opportunities, and helping nurture economic development in British Columbia through the life sciences industry.
What does LifeSciences BC do?
Here are just a few of the activities LifeSciences BC carries out under our four strategic areas:
1. Active Facilitation of Investment and Partnering
LifeSciences BC connects our Members and Sponsors to global investors and strategic partners through several avenues including:
LifeSciences BC's on-line directory of companies, research institutions and technologies
Regular targeted strategic partnering events with top-tier multinationals
Co-producing of the annual BioPartnering North America, the largest stand-alone biopharma partnering event on the continent, and an event that regularly attracts delegates from over 25 countries
Our Life Sciences Ambassador Programme, whereby Members' and Sponsors' international business development objectives are supported by a seasoned LifeSciences BC executive on the ground in Europe. This representative is also connected to a global network of fellow Ambassadors in order to build the international partnerships companies are looking for.
Hosting of additional international conferences in British Columbia such as BIO's 2008 Pacific Rim Summit on Industrial Biotechnology and Bioenergy
Regular hosting of incoming business and research delegations from around the world, and coordination of outgoing BC missions to leading international clusters
2. Advocacy and Public Policy Development
LifeSciences BC is regularly consulted by local, national and international bodies on a variety of issues related to science and technology, research and innovation. Through these consultations, we ensure that the BC life sciences industry has a voice at every table, and that voice is one of credible insight into not only the development of our local life sciences industry, but how science and technology affects the lives of everyone globally.
LifeSciences BC also proactively ensures that life sciences is a key priority on the agendas of our various levels of government, and positions the industry as a valuable partner in bettering our city, province and country. By working directly with government on a vast array of policy recommendations, we aim to create an environment which enables the successful execution of Members' and Sponsors' business development goals.
Following are just a few examples of our advocacy efforts and successes:
Development of our position paper, Building World-Class Biotech Businesses in BC — a blueprint for both government and industry to reach our full potential as a leading life sciences cluster
Formal submissions to key consultations such as the BC Conversation on Health and annual budget planning cycles
Leading role on the Pharmacare Taskforce, a collaboration between academia, industry and government whose twelve recommendations on BC's Pharmacare program were accepted in their entirety by the Provincial Government
Collaboration with the Provincial Government to gain approval for enhanced federal Intellectual Property and Data Protection
Introduction of changes to the provincial International Financial Activities Act to provide companies deriving income from life sciences patents tax savings of up to $8 million/year
3. Marketing and Promotion of our World-Class Science and Life Sciences Industry
LifeSciences BC actively works to raise the local, national and international profile of the companies and research institutions that make up British Columbia's life sciences industry. These efforts have led to major international exposure for Members and Sponsors, and subsequent investments and partnering deals. Below are some of the promotion vehicles we continually manage and utilize:
A coordinated strategic British Columbia presence at major international life science conferences such as BIO, BioPartnering Europe, The World Congress on Industrial Biotechnology, BioJapan and AusBiotech to name just a few
Production of the Annual LifeSciences BC Awards to recognize exceptional individuals and companies for their contributions to the industry, and to highlight to the local community, the importance of the life sciences sectors
A robust website that receives over 15,000 hits a month, and that acts as a central portal into all things life sciences in BC, including industry news and events, statistics and information, business development opportunities, resources, employment opportunities, and much more
Biolinks — LifeSciences BC's monthly electronic life sciences newsletter distributed globally to over 5,000 key contacts
4. Development and Support of our Human Capital Through Member Mentoring, Education and Networking
Through LifeSciences BC, Members and Sponsors are provided the opportunity to get informed on the latest issues affecting the industry, get connected to their peers, and get personal advice from industry leaders and experts. Following are just a few ways in which we enable this:
LifeSciences BC's BC Excels Mentorship Program for executives from emerging companies seeking to enhance their own professional development, and their company's product plan, commercialization and intellectual property protection strategies
Quarterly Breakfast Speaking Series featuring national and international industry leaders and local companies
Medical Device and BioProducts and BioEnergy Seminar Series to address topics of specific relevance to members from these sectors
Monthly Industry Roundtables on topics of relevance to all member sectors
Our Annual Salmon Barbeque — a networking event that every year brings together over 200 members of the broad life sciences community
Delivery of Biotech 101 — Biotechnology and Beyond: Introduction to the Life Sciences Industry two-day course for non-scientists
Delivery of the sanofi-aventis BioTalent Challenge — a science fair competition for high school students where they are mentored by a scientist from our community